BlueGene Biotech News Center
-
Host Cell Protein Assay Platform: How Much Process-Specific Consideration Does IND/BLA Filing Require?
In the manufacture of monoclonal and polyclonal antibody therapeutics, residual impurities derived from cell culture media, growth supplements, antibiotics, and process-related reagents must be clearl...
Sep.01, 2026
Read More >
-
A New Track in Insect Cell Expression: High-Five (Hi-5) HCP Precision Quality Control Solution
BACKGROUD:Origin: The insect cell expression system has emerged as one of the hosts for innovative drug development in recent years. Although it occupies a niche market, it offers specific advantages in t...
May.27, 2026
Read More >
-
Cellgene Bioscience Appears at the 7th BIONNOVA Forum: Focusing on HCP, Facilitating Drug Discovery and Quality Control Monitoring
From April 22nd to 23rd, 2026, the 7th BIONNOVA Biomedical Innovators Forum and Exhibition was grandly held at the Zhangjiang Science and Technology Center in Shanghai. This conference brought togeth...
May.15, 2026
Read More >